Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.87 USD
Change Today +0.27 / 2.33%
Volume 75.6K
FOMX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Meir Eini

Co-Founder, Chairman of the Board and Chief Innovation Officer, Foamix Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
59$422,242
As of Fiscal Year 2014

Background*

Mr. Meir Eini is a Co-Founder of Foamix Pharmaceuticals Ltd. and serves as its Chief Innovation Officer. Mr. Eini served as Chief Operating Officer at Foamix Pharmaceuticals Ltd., since January 2003. He co-invented the Foamix Oil Gel and Foam technologies. He is an experienced entrepreneur and has many years of experience in the initiation, setting-up and running of technology-oriented businesses including the set-up and operation of a US subsidiary of Sharnoa LTD (industrial ...

Read Full Background

Corporate Headquarters*

2 Holzman Street
Rehovot, -- 76704

Israel

Phone: 972 8 931 6233
Fax: --

Board Members Memberships*

Co-Founder, Chairman of the Board and Chief Innovation Officer

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$202,026
Bonus$118,025
Total Annual Compensation$320,051

Stock Options*

All Other Compensation$101,808

Total Compensation*

Total Annual Cash Compensation$421,859
Total Short Term Compensation$320,051
Other Long Term Compensation$101,808
Total Calculated Compensation$422,242
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOMX:US $11.87 USD +0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Barry D. Quart Pharm.D.Chief Executive Officer and Director
Heron Therapeutics, Inc.
$540.8K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOAMIX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.